Back to search
FDAFDA · Food and drugs·Recall number D-0826-2018

Diclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0.2 mg, 60-count bottle, Rx Only, Manufactured by: Cipla Ltd., India; For: EAGLE PHARMACEUTICALS, INC., Woodcliff Lake, NJ 07677 USA, NDC 42367-111-06.

Published May 30, 2018 · Recall initiated: April 20, 2018

Summary

FDA records drug Class II recall D-0826-2018, published May 30, 2018 and initiated April 20, 2018. Recalling firm: Exela Pharma Sciences LLC; Status: Terminated; Reported quantity: 5256 bottles; Lot: Lot: GH70154, Exp 12/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Mix-Up: bottle labeled as Diclofenac Sodium and Misoprostol 75 mg/0.2 mg contained Diclofenac Sodium and Misoprostol 50 mg/0.2 mg tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Exela Pharma Sciences LLC
Distributor
Nationwide in the USA and Puerto Rico
Lot
Lot: GH70154, Exp 12/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Diclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0.2 mg, 60-count bottle, Rx Only, Manufactured by: Cipla Ltd., India; For: EAGLE PHARMACEUTICALS, INC., Woodcliff Lake, NJ 07677 USA, NDC 42367-111-06. recalled?

Yes. FDA published recall D-0826-2018 on May 30, 2018. Reported hazard: Labeling: Label Mix-Up: bottle labeled as Diclofenac Sodium and Misoprostol 75 mg/0.2 mg contained Diclofenac Sodium and Misoprostol 50 mg/0.2 mg tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter